• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

该国西部最大的传染病和肺痨病医院收治的新型冠状病毒肺炎患者死亡及病情好转情况分析

Analysis of Deaths and Favorable Developments of Patients with SARS-CoV-2 Hospitalized in the Largest Hospital for Infectious Diseases and Pneumo-Phthisiology in the West of the Country.

作者信息

Laza Ruxandra, Dragomir Cristina, Musta Virgil Filaret, Lazureanu Voichita Elena, Nicolescu Narcisa Daniela, Marinescu Adelina Raluca, Paczeyka Roxana, Porosnicu Tamara Mirela, Bica-Porfir Valerica, Laitin Sorina Maria Denisa, Dragomir Ion, Ilie Constantin, Baditoiu Luminita Mirela

机构信息

Department XIII, Discipline of Infectious Diseases, University of Medicine and Pharmacy "Victor Babes", Timisoara, Romania.

Clinical Hospital of Infectious Diseases and Pneumophtisiology "Doctor Victor Babes", Timisoara, 300310, Romania.

出版信息

Int J Gen Med. 2022 Mar 29;15:3417-3431. doi: 10.2147/IJGM.S359483. eCollection 2022.

DOI:10.2147/IJGM.S359483
PMID:35378919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8976499/
Abstract

PURPOSE

Romania is one of the European countries that has been hit the hardest by the severe acute respiratory syndrome caused by the new coronavirus SARS-CoV-2, with over 1.91 million reported cases and over 59,257 deaths. The aim of this study was to identify the main predictors of death in hospitalized patients.

PATIENTS AND METHODS

In the period from 1 March 2020 to 30 June 2021, an observational, retrospective, randomized, case-control study was conducted, which included a sample of 139 patients who died in hospital and another sample of 275 patients who had been discharged in an improved or healed condition. Confirmation of COVID-19 cases was performed by RT-PCR from nasopharyngeal and oropharyngeal exudates. Statistical data were analyzed by logistic regression, Cox regression and a comparison of survival curves by the log-rank (Mantel-Cox) test.

RESULTS

The most powerful logistic regression model identified the following independent predictors of death: history of coagulopathy HR = 30.73 [1.94-487.09], p = 0.015; high percentage of neutrophils HR = 1.09 [1.01-1.19], p = 0.027; and decreased blood-oxygenation HR = 53881.97 [1762.24-1647489.44], p < 0.001. Cox regression identified the following factors that influenced the evolution of cases: history of coagulopathy HR = 2.44 [1.38-4.35], p = 0.000; O saturation HR = 0.98 [0.96-0.99], p = 0.043; serum creatinine HR = 1.23 [1.08-1.39], p = 0.001; dyspnea on admission HR = 2.99 [1.42-6.30], p = 0.004; hospitalization directly in the ICU HR = 3.803 [1.97-7.33], p < 0.001; heart damage HR = 16.76 [1.49-188.56], p = 0.022; and decreased blood-oxygenation HR = 35.12 [5.92-208.19], p < 0.001.

CONCLUSION

Knowledge of the predictors of death in hospitalized patients allows for the future optimization of triage and therapeutic case management for COVID-19.

摘要

目的

罗马尼亚是受新型冠状病毒SARS-CoV-2引起的严重急性呼吸综合征影响最严重的欧洲国家之一,报告病例超过191万例,死亡超过59257例。本研究的目的是确定住院患者死亡的主要预测因素。

患者与方法

在2020年3月1日至2021年6月30日期间,进行了一项观察性、回顾性、随机、病例对照研究,其中包括139例在医院死亡的患者样本和275例病情好转或治愈出院的患者样本。通过对鼻咽和口咽分泌物进行逆转录聚合酶链反应(RT-PCR)来确诊COVID-19病例。采用逻辑回归、Cox回归以及对数秩(Mantel-Cox)检验比较生存曲线对统计数据进行分析。

结果

最有力的逻辑回归模型确定了以下死亡的独立预测因素:凝血病病史HR = 30.73 [1.94 - 487.09],p = 0.015;中性粒细胞百分比高HR = 1.09 [1.01 - 1.19],p = 0.027;血氧降低HR = 53881.97 [1762.24 - 1647489.44],p < 0.001。Cox回归确定了以下影响病例进展的因素:凝血病病史HR = 2.44 [1.38 - 4.35],p = 0.000;血氧饱和度HR = 0.98 [0.96 - 0.99],p = 0.043;血清肌酐HR = 1.23 [1.08 - 1.39],p = 0.001;入院时呼吸困难HR = 2.99 [1.42 - 6.30],p = 0.004;直接入住重症监护病房(ICU)HR = 3.803 [1.97 - 7.33],p < 0.001;心脏损伤HR = 16.76 [1.49 - 188.56],p = 0.022;血氧降低HR = 35.12 [5.92 - 208.19],p < 0.001。

结论

了解住院患者死亡的预测因素有助于未来优化COVID-19的分诊和治疗病例管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/8976499/61e20d381aff/IJGM-15-3417-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/8976499/5ccc202f0435/IJGM-15-3417-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/8976499/61e20d381aff/IJGM-15-3417-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/8976499/5ccc202f0435/IJGM-15-3417-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/8976499/61e20d381aff/IJGM-15-3417-g0002.jpg

相似文献

1
Analysis of Deaths and Favorable Developments of Patients with SARS-CoV-2 Hospitalized in the Largest Hospital for Infectious Diseases and Pneumo-Phthisiology in the West of the Country.该国西部最大的传染病和肺痨病医院收治的新型冠状病毒肺炎患者死亡及病情好转情况分析
Int J Gen Med. 2022 Mar 29;15:3417-3431. doi: 10.2147/IJGM.S359483. eCollection 2022.
2
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
3
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
4
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.大量 COVID-19 住院血液透析患者死亡的决定因素。
BMC Nephrol. 2021 Jan 14;22(1):29. doi: 10.1186/s12882-021-02233-0.
5
Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.沙特阿拉伯住院患者中的糖尿病和新冠病毒-19:一项单中心回顾性研究。
Cardiovasc Diabetol. 2020 Dec 5;19(1):205. doi: 10.1186/s12933-020-01184-4.
6
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
7
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.摩洛哥卡萨布兰卡新冠肺炎患者严重程度的预测因素
Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716.
8
Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.新型冠状病毒肺炎患者的急性肾损伤:城市内医院的经验及政策影响。
Am J Nephrol. 2020;51(10):786-796. doi: 10.1159/000511160. Epub 2020 Oct 2.
9
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
10
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.SARS-CoV-2 再感染可疑病例的发生率和严重程度在一组 PCR 阳性 COVID-19 患者中的研究。
Clin Microbiol Infect. 2021 Dec;27(12):1860.e7-1860.e10. doi: 10.1016/j.cmi.2021.07.030. Epub 2021 Aug 19.

引用本文的文献

1
Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future.新型冠状病毒的新型受体、突变、疫苗及应对模式的建立:现状与未来
Front Microbiol. 2023 Aug 14;14:1232453. doi: 10.3389/fmicb.2023.1232453. eCollection 2023.
2
A Retrospective Assessment of Sputum Samples and Antimicrobial Resistance in COVID-19 Patients.COVID-19患者痰液样本及抗菌药物耐药性的回顾性评估
Pathogens. 2023 Apr 19;12(4):620. doi: 10.3390/pathogens12040620.

本文引用的文献

1
Study on the Refusal of Vaccination against COVID-19 in Romania.罗马尼亚新冠疫苗接种拒绝情况研究
Vaccines (Basel). 2022 Feb 9;10(2):261. doi: 10.3390/vaccines10020261.
2
COVID-19 in Romania: What Went Wrong?罗马尼亚的新冠疫情:哪里出了问题?
Front Public Health. 2021 Dec 17;9:813941. doi: 10.3389/fpubh.2021.813941. eCollection 2021.
3
Coronavirus seasonality, respiratory infections and weather.冠状病毒的季节性、呼吸道感染和天气。
BMC Infect Dis. 2021 Oct 26;21(1):1101. doi: 10.1186/s12879-021-06785-2.
4
Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy.不同剂量普通肝素与依诺肝素钠对新型冠状病毒肺炎相关凝血病病程影响的比较
Life (Basel). 2021 Sep 30;11(10):1032. doi: 10.3390/life11101032.
5
Coping Strategies and Stress Related Disorders in Patients with COVID-19.新型冠状病毒肺炎患者的应对策略与应激相关障碍
Brain Sci. 2021 Sep 28;11(10):1287. doi: 10.3390/brainsci11101287.
6
The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study.新冠病毒疾病入院生存评估(CASA)指数:一项为期12个月的观察性研究。
Front Med (Lausanne). 2021 Sep 30;8:719976. doi: 10.3389/fmed.2021.719976. eCollection 2021.
7
Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients.新冠病毒病患者的门诊和住院抗凝治疗以及住院和死亡风险
EClinicalMedicine. 2021 Nov;41:101139. doi: 10.1016/j.eclinm.2021.101139. Epub 2021 Sep 24.
8
CT-Based Risk Stratification for Intensive Care Need and Survival in COVID-19 Patients-A Simple Solution.基于CT的新冠病毒肺炎患者重症监护需求及生存风险分层——一个简单的解决方案
Diagnostics (Basel). 2021 Sep 4;11(9):1616. doi: 10.3390/diagnostics11091616.
9
Factors associated with the difference between the incidence and case-fatality ratio of coronavirus disease 2019 by country.与 2019 冠状病毒病发病率和病死率在各国之间存在差异相关的因素。
Sci Rep. 2021 Sep 23;11(1):18938. doi: 10.1038/s41598-021-98378-x.
10
COVID-19 mortality with regard to healthcare services availability, health risks, and socio-spatial factors at department level in France: A spatial cross-sectional analysis.法国部门层面医疗服务可及性、健康风险和社会空间因素与 COVID-19 死亡率的关系:空间横断面分析。
PLoS One. 2021 Sep 17;16(9):e0256857. doi: 10.1371/journal.pone.0256857. eCollection 2021.